SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
-------------------
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D) OF
THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported) September 19, 2003
ICU MEDICAL, INC.
(Exact name of registrant as specified in its charter)
DELAWARE 0-19974 33-0022692
-------- ------- ----------
(State or other jurisdiction (Commission File Number) (I.R.S. Employer
of incorporation) Identification No.)
951 Calle Amanecer, San Clemente, California 92673
-------------------------------------------- -----
(Address of principal executive offices) (Zip Code)
(949) 366-2183
--------------
Registrant's telephone number, including area code
N/A
---
(Former name or former address, if changed since last report)
INFORMATION TO BE INCLUDED IN THE REPORT
Item 5. Other Events
------------
ICU Medical, Inc. announced that it will be making a presentation at
the UBS Global Life Sciences Conference on September 24, 2003.
Item 7. Financial Statements and Exhibits
(c) Exhibits
1 Press release, dated September 19, 2003, announcing that ICU
Medical, Inc.'s will present at the UBS Global Life Sciences
Conference on September 24, 2003.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this Report to be signed on its behalf by the
undersigned hereunto duly authorized.
Date: September 19, 2003
ICU MEDICAL, INC.
/s/ Francis J. O'Brien
-------------------------
Francis J. O'Brien
Secretary, Treasurer and
Chief Financial Officer
Exhibit 1
ICU MEDICAL, INC.
ICU MEDICAL, INC. TO PRESENT AT
UBS GLOBAL LIFE SCIENCES CONFERENCE
SEPTEMBER 19, 2003, SAN CLEMENTE, CALIFORNIA --ICU Medical, Inc.,
(NASDAQ/NMS:ICUI), the San Clemente based maker of safe medical connectors and
custom intravenous systems, today announced that Frank O'Brien, ICU Medical's
Chief Financial Officer, will be presenting information about the Company of
significant interest to the investment community at the annual UBS Global Life
Sciences Conference. The presentation will be held at the Plaza Hotel in New
York and is scheduled for 3:00 p.m. EDT on September 24, 2003.
A live webcast of the presentation will be available through the UBS
website at www.ibb.ubs.com; click on the "conference" link, and follow the link
for the Webcast under the Global Life Sciences Conference heading. ICU Medical,
Inc. will post its presentation material on its website at www.icumed.com.
CONTACT: Francis J. O'Brien
Chief Financial Officer
ICU Medical, Inc.
(949) 366-2183